XHKG
1207
Market cap34mUSD
Mar 31, Last price
0.01HKD
Name
SRE Group Ltd
Chart & performance
P/E
—
P/S
0.38
EPS
—
Div yield, %
—
Shs. 5Y
—
Rev. 5Y
-17.34%
Revenues
599m
+182.41%
Net income
-1.62b
L+504.27%
CFO
-2m
L-96.27%
Dividend
Jun 03, 20140.0106 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
SRE Group Limited, alongside its various operating units, primarily undertakes real estate development and investment ventures, predominantly within Mainland China. Its property development division is responsible for constructing and marketing both residential and commercial buildings. Additionally, the company's property leasing segment manages the rental of office and retail spaces. Beyond its core real estate activities, SRE Group holds interests in diverse sectors, notably operating hospitals that provide a range of medical services such as outpatient care, pharmaceutical distribution, obstetrics, gynecology, and specialized postpartum care for inpatients. Furthermore, its service portfolio encompasses real estate brokerage, financial factoring, property administration, construction services, procurement management, and the advancement of housing-related technology. Founded in 1993, the enterprise maintains its principal office in Admiralty, Hong Kong, and operates as a subordinate entity of Jiashun (Holding) Investment Limited.
Key people
Dechao Lei
Executive Chairman of the Board · since 2020
Xiongwen Peng
Chief Financial Officer · since 2019
Donghui Chen
Executive Director · since 2016
Chao Chen
Executive Director · since 2015
Chuming Jiang
Executive Director · since 2019
Qi Jiang
Executive Director · since 2018
Xinkuang Peng
Executive Chairman of the Board, Chief Executive Officer · since 2019
Wenying Qin
Executive Director · since 2016
Qiang Zhu
Executive Director · since 2015
Hoe Tin Chu
Company Secretary · since 2019
Non-Executive Independent Director · since 2012
Ping Guo
Independent Non-Executive Director · since 2014
Gensheng Han
Non-Executive Independent Director · since 2016
Independent Non-Executive Director · since 2016
Independent Non-Executive Director · since 2010
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||